Home > Riviste > Minerva Gastroenterologica e Dietologica > Fascicoli precedenti > Minerva Gastroenterologica e Dietologica 2016 December;62(4) > Minerva Gastroenterologica e Dietologica 2016 December;62(4):316-24

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

MINERVA GASTROENTEROLOGICA E DIETOLOGICA

Rivista di Gastroenterologia, Nutrizione e Dietetica


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

REVIEWS  


Minerva Gastroenterologica e Dietologica 2016 December;62(4):316-24

lingua: Inglese

Glutathione in the treatment of liver diseases: insights from clinical practice

Rodolfo SACCO 1, Roberto EGGENHOFFNER 2, Luca GIACOMELLI 2

1 Department of Gastroenterology, Cisanello Hospital, Pisa, Italy; 2 Department of Surgical Sciences and Integrated Diagnostics, School of Medicine, University of Genoa, Genoa, Italy


PDF  


Liver diseases markedly contribute to the global burden of mortality and morbidity. The pathogenesis of alcohol- and non-alcohol-induced liver diseases is complex, and many factors have been described to contribute to the progressive loss of liver functions, including the over-generation of reactive oxygen species. Glutathione (GSH) is the most important low-molecular-weight antioxidant synthesized in cells, as it is a reducing molecule which can react to oxygen species by neutralizing the unpaired electrons that make them highly reactive and dangerous. ROS over-production impairs the intracellular GSH homeostasis, leading to GSH deficiency, a pathophysiological hallmark in alcoholic and non-alcoholic liver diseases.Judging on the basis of the evidence obtained from experimental research and previous clinical studies, GSH administration seems to be a promising strategy to recover oxidative stress-induced liver damages in alcoholic and non-alcoholic liver diseases.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

lu.giacomelli6@gmail.com